跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zefei - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zefei
Approved
STANDARD
Zefei
Jiangsu Hansoh Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
64e0943b6f1d0e90
Company
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
64e0943b6f1d0e90
Drug Approval Philippines Name
Zefei
Product Name
Zefei
Registration Number
DR-XY33194
Brand Name
Zefei
Generic Name
Gemcitabine (as hydrochloride)
Dosage Form
Lyophilized Powder for Solution for Infusion (IV)
Dosage Strength
1 g
Manufacturer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Importer
Goodfellow Pharma Corporation
Distributor
Goodfellow Pharma Corporation
Issuance Date
25 July 2022
Expiry Date
25 July 2027
Pharmacologic Category
Antineoplastic (Pyrimidine analogue)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
64e0943b6f1d0e90
Type
Standard
Back to Philippines FDA Approvals